Hugel

Chuncheon-si, South Korea Founded: 2001 • Age: 25 yrs Acquired By CBC Group
Therapeutics in aesthetics are developed, including botulinum toxin products.
Request Access

About Hugel

Hugel is a company based in Chuncheon-si (South Korea) founded in 2001 was acquired by CBC Group in May 2022.. The company has 609 employees as of December 31, 2024. Hugel has completed 1 acquisition, including JW Cosmetic. Hugel operates in a competitive market with competitors including Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.

  • Headquarter Chuncheon-si, South Korea
  • Employees 609 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Hugel, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $252.95 M (USD)
    16.69
    as on Dec 31, 2024
  • Net Profit
    $92.09 M (USD)
    45.92
    as on Dec 31, 2024
  • EBITDA
    $122.91 M (USD)
    37.74
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
    Mubadala

    & 4 more

  • Employee Count
    609

    as on Dec 31, 2024

  • Investments & Acquisitions
  • Acquired by
    CBC Group

    & 1 more

    (May 24, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Hugel

Hugel is a publicly listed company on the KRX with ticker symbol 145020 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 145020 . Sector: Health technology · South Korea

Funding Insights of Hugel

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Hugel

Hugel has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Mubadala, Bain Capital Private Equity and CBC Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private investment firm managing assets and expanding into equity, credit, and real estate services.
Founded Year Domain Location
Growth stage companies are targeted for private equity investments.
Founded Year Domain Location
Sovereign wealth fund of United Arab Emirates
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Hugel

Hugel has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include JW Cosmetic. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Manufacturer of skin care products
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Hugel

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Hugel Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Hugel

Hugel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
domain founded_year HQ Location
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
domain founded_year HQ Location
Small molecule therapeutics for inflammatory skin diseases are developed.
domain founded_year HQ Location
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
domain founded_year HQ Location
Therapeutics for multiple diseases including dermatology and neurology are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Hugel

Frequently Asked Questions about Hugel

When was Hugel founded?

Hugel was founded in 2001.

Where is Hugel located?

Hugel is headquartered in Chuncheon-si, South Korea. It is registered at Chuncheon-si, Gangwon-do, South Korea.

How many employees does Hugel have?

As of Dec 31, 2024, the latest employee count at Hugel is 609.

What is the annual revenue of Hugel?

Annual revenue of Hugel is $252.95M as on Dec 31, 2024.

What does Hugel do?

Hugel was founded in 2001 in Chuncheon-si, South Korea, where operations focus on the aesthetics sector. Therapeutics based on botulinum toxin from the Clostridium Botulinum CBFC26 strain are produced for applications such as pediatric cerebral palsy treatment. Biomaterial solutions like Chaeum Premium are also offered for tissue restoration purposes. The companys domain is hugel.co.kr, supporting its work in pharmaceutical development.

Who are the top competitors of Hugel?

Hugel's top competitors include Revance Therapeutics, Dermavant and Bausch Health.

Is Hugel publicly traded?

Yes, Hugel is publicly traded on KRX under the ticker symbol 145020.

How many acquisitions has Hugel made?

Hugel has made 1 acquisition, including JW Cosmetic.

Who are Hugel's investors?

Hugel has 5 investors. Key investors include Mubadala, Bain Capital Private Equity, CBC Group, IMM Korea, and GS Holdings.

What is Hugel's ticker symbol?

The ticker symbol of Hugel is 145020 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available